A PVRI Symposium: Genetics-inspired Therapeutics for Pulmonary Hypertension

2 June 2026

Join us for this one-day genetics-inspired therapeutics for pulmonary hypertension (PH) symposium to review our current understanding of the genetics of PH, the impact on therapeutic drug development and the potential to deliver further therapeutic gains.

2 June 2026
09:00 - 18:30 GMT
Royal College of Physicians, London

Programme

Genetic discovery has transformed how we understand PAH. This symposium brings together global experts to examine what that means in practice – for biology, clinical trials, and future therapies.

Across the day, the programme will explore four core themes:

08:00 - 09:00: Registration and refreshments
09:05 - 10:00: Genetic insights into pulmonary vascular disease
10:05 - 12:30: Therapeutic agents targeting the TGF-β/BMP pathway – Part 1
13:30 - 15:30: Therapeutic agents targeting the TGF-β/BMP pathway – Part 2
16:00 - 17:00: Developing therapeutic agents to target other genetically validated pathways
17:00 - 18:30: Networking reception

The programme combines scientific depth with practical discussion, creating space for critical thinking, collaboration, and forward-looking debate.

Patrick Andre, Diagonal Therapeutics
Ardeschir Ghofrani, Justus-Liebig-Universität Gießen/ University Clinic Giessen
Marie-Jose Goumans, Leiden University
Rachel Gurrell, Apollo Therapeutics
Lars Harbaum, Universitätsklinikum Hamburg-Eppendorf
Kevin Hart, Pfizer
Wei Li, VPD-Heart and Lung Research Insitute, University Of Cambridge
Maureen O’Connor, 35Pharma
Chris Rhodes, Imperial College London
Alex Rothman, The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation Trust
Ana-Maria Tanase, Novartis
Khodr Tello, Justus Liebig University Giessen
Richard Trembath, King's College London
Paul Yu, Mass General Brigham

Michaela Aldred, Indiana University
Stefan Graf, University of Cambridge
Luke Howard, Imperial College Healthcare NHS Trust
Jane Leopold, Harvard University
Brad Maron, University of Maryland
Nick Morrell, University of Cambridge
Laura Southgate, University of London

Explore the full programme

Interested? Watch this short video below of Martin Wilkins, Professor of Clinical Pharmacology, Imperial College London, to learn more.

Event location and getting there

This symposium will take place at the Royal College of Physicians, London, located in Regent’s Park in central London.

The venue is easily accessible by public transport:

Underground: Great Portland Street (Circle, Hammersmith & City, and Metropolitan lines), Regent’s Park (Bakerloo line), and Warren Street (Victoria and Northern lines) are all within walking distance
Mainline rail: London Euston and London King’s Cross St Pancras are a short taxi or Underground journey away
Airports: Heathrow, Gatwick, and London City Airport all offer direct rail links into central London

We recommend travelling by public transport where possible, as parking in the area is limited.

Please note that we do not have any reserved or recommended hotels for this event. There are numerous accommodation options nearby in Regent’s Park, Marylebone, Fitzrovia, and the wider central London area to suit a range of budgets.

If you’re travelling internationally, we encourage you to book accommodation early, as June is a busy period in London.

Registration will open soon

We’ve kept registration fees accessible to encourage broad participation across the global PH community. To check if you are in a low/middle-income country, please visit unstats.un.org/sdgs/indicators/regional-groups.

Early career / trainee / low- or middle-income country / non-profit / nurse rate - £80
Senior career level in a high-income country - £160
Pharmaceutical / industry rate - £280

If you’re a PVRI member, you’re entitled to a discounted rate. Please click here to access your discount code and reduced fee.

If you have any questions about registration, contact us at events@pvrinstitute.org and we’ll be happy to help.